Media

News releases

  • Series A Financing Round

    24 SEPTEMBER 2026 - Kasvu Therapeutics Raises €30 Million Series A Financing Round led by Hadean Ventures to Advance its Novel TrkB Potentiator into Clinical Development Targeting Neuropsychiatric Disorders

    Read full press release

Upcoming events

  • 29 SEPTEMBER 2026 – Oppenheimer Private Life Sciences Company Showcase (Virtual)

  • 9-11 NOVEMBER 2026 – BIO-Europe, Cologne

  • 16-19 NOVEMBER 2026 – Jefferies Global Healthcare Conference, London

  • 11-14 JANUARY 2027 - 45th Annual J.P. Morgan Healthcare Conference, San Francisco here